Eli Lilly commits $5.3B to more Zepbound, Mounjaro production
Boosting production and creating jobs, Eli Lilly invests $5.3 billion in Indiana plants for Zepbound and Mounjaro, with potential label expansion for ...
Read more at Becker's Hospital Review